FALCPA and Shared Equipment Disclosure: What Food Manufacturers Must Know
When allergens are present in a manufacturing facility on shared equipment, FALCPA guidance on precautionary labelling applies. Here is what manufacturers need to understand.
Many food manufacturers produce multiple products on shared equipment. When different products run on the same line — some containing major allergens, some not — there is a risk of cross-contact that may require disclosure on the label.
The Voluntary Nature of "May Contain" Statements
Under FALCPA, precautionary allergen labelling — "May contain...", "Made in a facility that also processes...", "Made on shared equipment with..." — is voluntary, not mandatory. There is no legal requirement to add these statements.
However, if cross-contact is reasonably likely based on your manufacturing process, failure to disclose a meaningful risk could constitute misbranding under broader FDA food labelling regulations.
FDA Guidance on Precautionary Labelling
The FDA has indicated that precautionary allergen statements should only be used when there is a genuine, meaningful risk of cross-contact — not as a blanket risk disclaimer added to every product regardless of actual risk. Overuse of "May contain" statements undermines their usefulness to allergic consumers who rely on them.
Risk Assessment for Shared Facilities
A documented risk assessment for each product produced on shared equipment should consider:
- Which allergens are present in the facility
- The cleaning and changeover procedures between runs
- Validation data for cleaning effectiveness
- The consequence of residual allergen presence for the specific allergen at issue
Connecting Risk Assessment to Label Decisions
The outcome of the risk assessment should drive the labelling decision. If cleaning validation confirms allergen removal to safe levels, a precautionary statement may not be warranted. If meaningful residual risk exists, disclosure is appropriate.
Understanding What FALCPA Actually Covers
FALCPA, the Food Allergen Labeling and Consumer Protection Act of 2004, requires that the nine major food allergens — milk, eggs, fish, shellfish, tree nuts, peanuts, wheat, soybeans, and sesame — be clearly declared on packaged food labels sold in the United States. This mandatory declaration applies to intentional ingredients only, meaning allergens that are deliberately included in the formulation. Cross-contact scenarios, by contrast, fall outside the scope of FALCPA's mandatory requirements, which is why precautionary labelling occupies a voluntary but still legally significant space.
The distinction matters enormously in practice. A manufacturer who adds peanut butter to a cookie recipe must declare peanuts as an ingredient under FALCPA — there is no discretion there. But the same manufacturer running a peanut-free oat bar on the same equipment that previously processed those cookies is dealing with a different regulatory question entirely. The obligation to disclose that residual risk comes not from FALCPA directly, but from the FDA's broader misbranding provisions under the Federal Food, Drug, and Cosmetic Act, which prohibit labels that are false or misleading in any particular.
Understanding this two-layer framework is essential for any food business operating at scale. Many small manufacturers conflate the two, either over-labelling out of caution in ways that erode consumer trust, or under-labelling because they assume FALCPA's explicit requirements represent the full extent of their obligations. Neither approach serves your business or your customers well. A clear-eyed understanding of where mandatory requirements end and where risk-based disclosure obligations begin is the foundation of a defensible labelling programme.
Designing a Cleaning Validation Programme
Cleaning validation is the technical backbone of any shared-equipment allergen control programme. Without documented evidence that your cleaning procedures actually remove allergens to acceptable levels, you cannot make a credible labelling decision in either direction. Validation typically involves running your cleaning protocol and then testing surfaces — and sometimes a flush or rinse product — for residual allergen protein using ELISA or lateral flow strip tests. The results tell you whether your procedure is fit for purpose and give you the data to support your label claims.
The validation process should be conducted for each allergen-containing product that runs on a given line, and it should be repeated whenever there is a significant change to the cleaning procedure, the equipment configuration, or the production schedule. A validation study done three years ago on equipment that has since been modified does not protect you today. Many manufacturers treat validation as a one-time exercise, but regulators and auditors increasingly expect it to be an ongoing, documented programme with defined revalidation triggers and clear records of outcomes.
When validation data shows that your cleaning procedure reliably removes residual allergen protein below a meaningful risk threshold, you have a reasonable scientific basis for omitting a precautionary statement. When the data shows that residual protein remains detectable after cleaning — or when you have not validated at all — the risk-based case for precautionary disclosure becomes much stronger. Investing in a robust cleaning validation programme is not just a regulatory exercise; it is a commercial one, because it gives you the evidence to make accurate, confident label claims that hold up under scrutiny.
Communicating Shared Equipment Risk to Online Customers
For manufacturers who also sell through e-commerce channels, including Shopify storefronts, there is an additional dimension to consider: how allergen and cross-contact information is communicated at the point of sale online. The physical label is the primary legal document, but many allergic consumers are making purchase decisions on a product page before they ever see the physical packaging. If the product page omits or contradicts the label's allergen information, you are creating a gap that could mislead a vulnerable shopper and expose your business to liability.
Best practice is to ensure that your online product descriptions reflect the same allergen and cross-contact information that appears on your physical label. If a label carries a "Made on shared equipment with tree nuts" statement, that disclosure should be present and visible on the corresponding product page — not buried in a download or absent entirely. Some Shopify merchants manage this manually, updating product descriptions each time a label changes, but this approach is error-prone at scale, particularly for businesses with large SKU counts or frequent reformulations.
Tools that centralise allergen data and push accurate information to your product pages consistently are increasingly important for food businesses selling online. The Allergen Matrix app at saltai.app is designed specifically for this workflow, allowing merchants to manage ingredient and allergen data in one place and reflect it accurately across their Shopify storefront. Keeping your physical label and your online listings aligned is not just good practice — for allergic consumers making safety-critical decisions, it is genuinely important.
Documenting Your Labelling Decisions
One aspect of allergen management that smaller manufacturers often neglect is documentation of the decision-making process behind each label. It is not enough to have conducted a risk assessment and arrived at a labelling decision — you need to be able to demonstrate, if challenged, why you made the choice you did. A well-documented record showing the allergens present in the facility, the cleaning procedure used, the validation data obtained, and the label decision that followed is your primary defence in the event of a complaint, an FDA inquiry, or a product liability claim.
Documentation should be structured so that it links specific products to specific risk assessments and specific label versions. If you update your cleaning procedure and revalidate, the new data should be tied to the label that was in use at that time. If you change a formulation and introduce a new allergen to a line, the documentation should capture when that change occurred and what label review followed. Version control matters here: a gap in the record, or a document that cannot be matched to a specific product run, weakens the evidentiary value of everything else.
Regulators conducting inspections of food facilities increasingly look for this kind of decision trail, particularly in the wake of allergen-related incidents. Demonstrating that your labelling decisions are evidence-based, consistently applied, and properly recorded signals that your allergen management programme is mature and credible. It also makes internal audits far more efficient, because staff can trace the logic behind any label without having to reconstruct it from memory or scattered files.
Staying Current as Regulations Evolve
The addition of sesame as the ninth major allergen under FASTER Act requirements, which took effect on 1 January 2023, is a recent illustration of how the regulatory landscape for food allergens in the United States continues to develop. Manufacturers who had well-established allergen management programmes still had to revisit their ingredient reviews, supplier declarations, shared-equipment assessments, and label copy to account for sesame. Businesses without systematic processes in place found that exercise significantly more burdensome than those who had built flexible, documented programmes from the outset.
Monitoring for regulatory changes is a non-trivial task for food businesses focused on production, sales, and growth. The FDA publishes guidance documents, constituent updates, and enforcement letters that can signal shifts in how existing requirements are being interpreted and applied, even when the underlying statute has not changed. Industry bodies, food law publications, and trade associations are useful sources, but they require active attention to be useful. Building a regular review cadence into your allergen management programme — at minimum annually, and whenever you learn of a significant regulatory development — is a practical safeguard.
The broader lesson from sesame's addition to the major allergen list is that allergen management cannot be a static, set-and-forget programme. Consumer science, regulatory expectations, and the commercial reality of selling food to allergy-aware shoppers are all moving targets. Manufacturers who treat allergen labelling as a living, actively managed part of their quality system are better positioned to adapt quickly, maintain compliance, and preserve the trust of the allergic consumers who depend on accurate labelling to make safe choices every day.
Manage allergen data for your manufacturing operation and Shopify product pages with Allergen Matrix at saltai.app.
Try Allergen Matrix free at saltai.app — no credit card required.
SaltAI Team
SaltAI builds focused Shopify apps for food merchants and general merchants. Every app is tested in production at a real food store — including Vanda's Kitchen — before it ships.